SCP-2024
Safe
~
medium confidence
SCP-2024
Expected annual
$869K
One-time setup
$809K
Annual recurring
$853K
Personnel
6
Initial setup and containment one-time costs are approximately $0.81M, mainly driven by investigation/containment field ops, contingency reserve, and equipment/remote-handling procurement. Recurring annual costs are approximately $0.85M/yr, driven by staff wages, a large medical contingency, ongoing research/testing, and administrative overhead.
One-Time Capital Costs
Total: $809K
Annual Recurring Costs
Total: $853K/yr
Cost Scenarios
📊
Baseline
(baseline)
$853K/yr
Normal year with routine operations, no major incidents or large-scale medical/containment events.
normal_operations
no_incidents
🚨
Minor Incident
$878K/yr
Small-scale incident such as a single minor tag tampering or low-severity staff exposure requiring extra testing and limited medical treatment.
minor_medical_case
small_disposal_event
minor_equipment_repair
🚨
Major Incident
$1.2M/yr
Accidental tag removal or operational lapse causing severe injury, hospitalization, and emergency research/response.
tag_removed_accidentally
severe_injury_hospitalization
emergency_research_response
🚨
Goi Infiltration
$953K/yr
Sustained Group-of-Interest attention or POI activity requiring expanded field ops, legal actions and ongoing countermeasures.
POI_activity
persistent_GoI_attention
extended_field_ops
🚨
Catastrophic Breach
$1.9M/yr
Severe uncontrolled escalation (widespread injuries, facility-level neutralization effort, mass medical response).
mass_casualties
neutralization_attempt
facility_breach
Personnel
6 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 4 | 24/7 security presence for vault and rapid-response team (matches item #6 staffing estimate). |
| Research Scientist | 2 | Containment technicians / materials or medical researchers for testing, monitoring and SOP updates (matches item #7). |
Confidence Notes
Analyst notes provide detailed line items and realistic ranges, allowing a mid-range quantified estimate; uncertainty remains due to choice between contracted testing vs capital purchases, regulatory costs for exotic materials, and low-probability high-cost incidents.